v3.25.2
Unaudited Condensed Consolidated Statements of Change in Stockholders’ Deficit - USD ($)
Preferred stock
Common stock
Additional paid in capital
Accumulated Deficit
Accumulated other comprehensive loss
Total
Balance at Dec. 31, 2023 $ 74 $ 1,528,926 $ (8,247,862) $ (1,075) $ (6,719,937)
Balance (in Shares) at Dec. 31, 2023 742,416 [1]        
Issuance of shares upon the reverse recapitalization $ 13 (2,833,487) (2,833,474)
Issuance of shares upon the reverse recapitalization (in Shares) 134,476 [1]        
Additional shares issued in connection with reverse recapitalization $ 1 (1)
Additional shares issued in connection with reverse recapitalization (in Shares) 5,114 [1]        
Stock compensation expense 171,897 171,897
Stock compensation expense (in Shares) 2,091 [1]        
Shares to be issued for stock compensation
Shares to be issued for stock compensation (in Shares) (2,091) [1]        
Foreign currency translation adjustments 50 50
Net loss (2,306,806) (2,306,806)
Balance at Mar. 31, 2024 $ 88 1,700,822 (13,388,155) (1,025) (11,688,270)
Balance (in Shares) at Mar. 31, 2024 882,006 [1]        
Balance at Dec. 31, 2023 $ 74 1,528,926 (8,247,862) (1,075) (6,719,937)
Balance (in Shares) at Dec. 31, 2023 742,416 [1]        
Foreign currency translation adjustments           (33)
Net loss           (4,075,125)
Balance at Jun. 30, 2024 $ 89 1,896,729 (15,156,474) (1,108) (13,260,764)
Balance (in Shares) at Jun. 30, 2024 887,006 [1]        
Balance at Mar. 31, 2024 $ 88 1,700,822 (13,388,155) (1,025) (11,688,270)
Balance (in Shares) at Mar. 31, 2024 882,006 [1]        
Stock compensation expense $ 1 195,907 195,908
Stock compensation expense (in Shares) 5,416 [1]        
Shares to be issued for stock compensation  
Shares to be issued for stock compensation (in Shares) (416) [1]        
Foreign currency translation adjustments (83) (83)
Net loss (1,768,319) (1,768,319)
Balance at Jun. 30, 2024 $ 89 1,896,729 (15,156,474) (1,108) (13,260,764)
Balance (in Shares) at Jun. 30, 2024 887,006 [1]        
Balance at Dec. 31, 2024 $ 246 10,396,274 (24,734,689) (981) (14,339,150)
Balance (in Shares) at Dec. 31, 2024 2,445,364 [1]        
Stock compensation expense $ 8 84,928 84,936
Stock compensation expense (in Shares) 84,091 [1]        
Shares to be issued for stock compensation
Shares to be issued for stock compensation (in Shares) (834) [1]        
Shares issued through warrants exercises $ 184 865,239 865,423
Shares issued through warrants exercises (in Shares) 1,839,023 [1]        
Shares issued through debt-to-equity conversion $ 57 (57)
Shares issued through debt-to-equity conversion (in Shares) 568,182 [1]        
Foreign currency translation adjustments 394 394
Net loss (2,019,811) (2,019,811)
Balance at Mar. 31, 2025 $ 495 11,346,384 (26,754,500) (587) (15,408,208)
Balance (in Shares) at Mar. 31, 2025 4,935,826 [1]        
Balance at Dec. 31, 2024 $ 246 10,396,274 (24,734,689) (981) (14,339,150)
Balance (in Shares) at Dec. 31, 2024 2,445,364 [1]        
Foreign currency translation adjustments           259
Net loss           (3,790,748)
Balance at Jun. 30, 2025 $ 753 11,554,958 (28,525,437) (722) $ (16,970,448)
Balance (in Shares) at Jun. 30, 2025 7,512,769 [1]       882,006
Balance at Mar. 31, 2025 $ 495 11,346,384 (26,754,500) (587) $ (15,408,208)
Balance (in Shares) at Mar. 31, 2025 4,935,826 [1]        
Stock compensation expense 60,957 60,957
Stock compensation expense (in Shares) [1]        
Shares issued through convertible notes conversion $ 258 147,617 147,875
Shares issued through convertible notes conversion (in Shares) 2,576,943 [1]        
Foreign currency translation adjustments (135) (135)
Net loss (1,770,937) (1,770,937)
Balance at Jun. 30, 2025 $ 753 $ 11,554,958 $ (28,525,437) $ (722) $ (16,970,448)
Balance (in Shares) at Jun. 30, 2025 7,512,769 [1]       882,006
[1] Giving retroactive effect to reverse recapitalization effected on March 11, 2024 and the 1-for-30 reverse stock split effected on November 21, 2024